JP7765681B2 - エクソソーム模倣物のラージスケール生成およびそれらの使用 - Google Patents
エクソソーム模倣物のラージスケール生成およびそれらの使用Info
- Publication number
- JP7765681B2 JP7765681B2 JP2022510109A JP2022510109A JP7765681B2 JP 7765681 B2 JP7765681 B2 JP 7765681B2 JP 2022510109 A JP2022510109 A JP 2022510109A JP 2022510109 A JP2022510109 A JP 2022510109A JP 7765681 B2 JP7765681 B2 JP 7765681B2
- Authority
- JP
- Japan
- Prior art keywords
- exosome
- disease
- cells
- cancer
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1896—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes not provided for elsewhere, e.g. cells, viruses, ghosts, red blood cells, virus capsides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
- A61B5/4058—Detecting, measuring or recording for evaluating the nervous system for evaluating the central nervous system
- A61B5/4064—Evaluating the brain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
- A61K9/5068—Cell membranes or bacterial membranes enclosing drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0693—Tumour cells; Cancer cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0033—Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room
- A61B5/0035—Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room adapted for acquisition of images from more than one imaging mode, e.g. combining MRI and optical tomography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0033—Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room
- A61B5/004—Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room adapted for image acquisition of a particular organ or body part
- A61B5/0042—Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room adapted for image acquisition of a particular organ or body part for the brain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0071—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by measuring fluorescence emission
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Neurology (AREA)
- Botany (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Psychology (AREA)
- General Physics & Mathematics (AREA)
- Oncology (AREA)
- Surgery (AREA)
- Medical Informatics (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962887876P | 2019-08-16 | 2019-08-16 | |
| US62/887,876 | 2019-08-16 | ||
| PCT/US2020/046050 WO2021034582A1 (en) | 2019-08-16 | 2020-08-13 | Large scale production of exosome mimetics and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022545656A JP2022545656A (ja) | 2022-10-28 |
| JP2022545656A5 JP2022545656A5 (cg-RX-API-DMAC7.html) | 2023-08-22 |
| JP7765681B2 true JP7765681B2 (ja) | 2025-11-07 |
Family
ID=74659601
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022510109A Active JP7765681B2 (ja) | 2019-08-16 | 2020-08-13 | エクソソーム模倣物のラージスケール生成およびそれらの使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220288241A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4013391A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7765681B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN114980869B (cg-RX-API-DMAC7.html) |
| CA (1) | CA3150734A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021034582A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12241888B2 (en) | 2018-03-14 | 2025-03-04 | Children's Medical Center Corporation | Platform for assessment of the transcytosis of extracellular vesicles across endothelial barriers and uses thereof |
| CN115137723B (zh) * | 2022-09-06 | 2023-05-05 | 深圳市茵冠生物科技有限公司 | 醋酸钙梯度主动载药法制备维a酸外泌体模拟物 |
| CN116200392B (zh) * | 2023-02-24 | 2026-08-11 | 杭州佰辰医学检验所有限公司 | 特异性结合丙戊酸钠小分子的核酸适配体、试剂盒及应用 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012532124A (ja) | 2009-07-01 | 2012-12-13 | イオン メディックス インコーポレイテッド | 哺乳類の有核細胞に由来するマイクロベシクル及びその用途 |
| CN108175759A (zh) | 2016-12-08 | 2018-06-19 | 暨南大学 | 一种抗肿瘤靶向给药系统及其制备方法与应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA037503B1 (ru) * | 2014-01-21 | 2021-04-05 | Анджариум Байосайенсиз Аг | Способ получения гибридосомы, гибридосома, полученная при помощи способа, и способ доставки терапевтического или диагностического средства |
| KR101720851B1 (ko) * | 2015-01-29 | 2017-03-28 | 포항공과대학교 산학협력단 | 세포의 지질막에서 유래된 나노소포체 및 이의 용도 |
| WO2019151744A1 (ko) * | 2018-01-31 | 2019-08-08 | 서울대학교산학협력단 | 성체줄기세포 유래의 나노베시클 및 이의 표적 치료용 용도 |
-
2020
- 2020-08-13 CA CA3150734A patent/CA3150734A1/en active Pending
- 2020-08-13 US US17/635,409 patent/US20220288241A1/en active Pending
- 2020-08-13 EP EP20855617.5A patent/EP4013391A4/en active Pending
- 2020-08-13 JP JP2022510109A patent/JP7765681B2/ja active Active
- 2020-08-13 WO PCT/US2020/046050 patent/WO2021034582A1/en not_active Ceased
- 2020-08-13 CN CN202080072463.2A patent/CN114980869B/zh active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012532124A (ja) | 2009-07-01 | 2012-12-13 | イオン メディックス インコーポレイテッド | 哺乳類の有核細胞に由来するマイクロベシクル及びその用途 |
| CN108175759A (zh) | 2016-12-08 | 2018-06-19 | 暨南大学 | 一种抗肿瘤靶向给药系统及其制备方法与应用 |
Non-Patent Citations (1)
| Title |
|---|
| KIM, H. Y. et al.,Therapeutic efficacy-potentiated and diseased organ-targeting nanovesicles derived from mesenchymal stem cells for spinal cord injury treatment,Nano Letters,2018年07月11日,Vol. 18, No. 8,P. 4965-4975 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN114980869B (zh) | 2024-08-27 |
| EP4013391A4 (en) | 2023-08-09 |
| CN114980869A (zh) | 2022-08-30 |
| EP4013391A1 (en) | 2022-06-22 |
| JP2022545656A (ja) | 2022-10-28 |
| US20220288241A1 (en) | 2022-09-15 |
| CA3150734A1 (en) | 2021-02-25 |
| WO2021034582A1 (en) | 2021-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yan et al. | Engineering cell membrane‐based nanotherapeutics to target inflammation | |
| Pulford et al. | Liposome-siRNA-peptide complexes cross the blood-brain barrier and significantly decrease PrPC on neuronal cells and PrPRES in infected cell cultures | |
| Srivastava et al. | Exploitation of exosomes as nanocarriers for gene-, chemo-, and immune-therapy of cancer | |
| Wang et al. | Exosomes: a novel strategy for treatment and prevention of diseases | |
| US20180311377A1 (en) | Drug delivery systems using fc fragments | |
| CN114980869B (zh) | 外排体模拟物的大规模产生及其用途 | |
| CN107427466B (zh) | 从细胞膜衍生的纳米囊泡及其用途 | |
| US12296016B2 (en) | Ceramide-like lipid-based delivery vehicles and uses thereof | |
| WO2011158933A1 (ja) | 腎線維症処置剤 | |
| US20250242046A1 (en) | Allogeneic hypoimmune biomimetic nanovesicle for the treatment of cancer | |
| US12383606B2 (en) | Short chain ceramide-based lipids and uses thereof | |
| JP2024525795A (ja) | Cldn6陽性癌を治療するための、cldn6およびcd3結合要素をコードする薬剤 | |
| JP2025518125A (ja) | 生体模倣型ナノ小胞を作製するための低免疫原性細胞 | |
| US20220275371A1 (en) | Use of rab7 gtpase (rab7) inhibitors in enhancing permeability of the blood brain barrier (bbb) | |
| US12551451B2 (en) | Compositions and methods for delivering molecules | |
| Jain et al. | A novel method for producing functionalized vesicles that efficiently deliver oligonucleotides in vitro and in vivo in mice | |
| JP2025538384A (ja) | 血球貪食性リンパ組織球症(hlh)関連疾患のための低免疫原性生体模倣ナノ小胞送達システム | |
| Nassar et al. | Extracellular vesicles: fundamentals and clinical relevance |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230814 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230814 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20240917 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20241101 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20250203 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250328 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20250702 |
|
| RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20250801 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20250801 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20250801 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251006 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7765681 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |